Author:
Chen Jing,Bao Cheng,Cho Se Haeng,Lee Hong Jin
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,Food Science,Biotechnology
Reference31 articles.
1. Doggrell SA. Lyprinol-is it a useful anti-inflammatory agent? Evid. Based Complement. Alternat. Med. 2011: 307121 (2011)
2. Cho SH, Jung YB, Seong SC, Park HB, Byun KY, Lee DC, Song EK, Son JH. Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial. Eur. Ann. Allergy. Clin. Immunol. 35: 212–216 (2003)
3. Gruenwald J, Graubaum HJ, Hansen K, Grube B. Efficacy and tolerability of a combination of Lyprinol and high concentrations of EPA and DHA in inflammatory rheumatoid disorders. Adv. Ther. 21: 197–201 (2004)
4. Hielm-Bjorkman A, Tulamo RM, Salonen H, Raekallio M. Evaluating complementary therapies for canine osteoarthritis part I: Green-lipped mussel (Perna canaliculus). Evid. Based Complement. Alternat. Med. 6: 365–373 (2009)
5. Lee CH, Lum JH, Ng CK, McKay J, Butt YK, Wong MS, Lo SC. Pain controlling and cytokine-regulating effects of lyprinol, a lipid extract of Perna canaliculus, in a rat adjuvant-induced arthritis model. Evid. Based Complement. Alternat. Med. 6: 239–245 (2009)
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献